-transparent.png){kind=logo}
Clonidine, an alpha 2-agonist, was studied in three male human subjects in a multi-dose pilot study in combination with smoking marijuana cigarettes. Marijuana alone caused increases in responses on subjective effect questionnaires and increased heart rate. Pretreatment with single oral doses of clonidine three hours prior to marijuana induced no changes in subjective effects prior to smoking marijuana and did not diminish the subjective effects produced by marijuana. Clonidine did substantially reduce but did not abolish the marijuana-induced rise in heart rate. Based on these preliminary data from three subjects, it is concluded that clonidine does not have therapeutic value in the clinical management of active marijuana abuse.
E J Cone, and
P Welch, and
W R Lange
June 1986,
Pharmacology, biochemistry, and behavior,
E J Cone, and
P Welch, and
W R Lange
September 1986,
Pharmacology, biochemistry, and behavior,
E J Cone, and
P Welch, and
W R Lange
January 1990,
Psychopharmacology,
E J Cone, and
P Welch, and
W R Lange
June 2010,
Drug and alcohol dependence,
E J Cone, and
P Welch, and
W R Lange
October 1983,
Journal of theoretical biology,
E J Cone, and
P Welch, and
W R Lange
November 1998,
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
E J Cone, and
P Welch, and
W R Lange
September 1989,
Pharmacology, biochemistry, and behavior,
E J Cone, and
P Welch, and
W R Lange
February 1998,
Pharmacology, biochemistry, and behavior,
E J Cone, and
P Welch, and
W R Lange
June 1986,
Clinical pharmacology and therapeutics,
E J Cone, and
P Welch, and
W R Lange
August 1983,
The American journal of nursing,
